Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
+$922M |
| 2 |
EOG Resources
EOG
|
+$517M |
| 3 |
Mastercard
MA
|
+$436M |
| 4 |
Las Vegas Sands
LVS
|
+$385M |
| 5 |
Booking.com
BKNG
|
+$382M |
Top Sells
| 1 |
Qualcomm
QCOM
|
+$660M |
| 2 |
Morgan Stanley
MS
|
+$519M |
| 3 |
PayPal
PYPL
|
+$479M |
| 4 |
Meta Platforms (Facebook)
META
|
+$478M |
| 5 |
Pfizer
PFE
|
+$405M |
Sector Composition
| 1 | Technology | 24.82% |
| 2 | Financials | 12.45% |
| 3 | Healthcare | 12.44% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Industrials | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2801
BioXcel Therapeutics
BTAI
$52.1M
| $958K | ﹤0.01% |
3,563
-201
| -5% | -$54K |
|
2802
MediaAlpha
MAX
$672M
| $956K | ﹤0.01% |
64,145
+810
| +1% | +$12.1K |
|
|
IMGO
2803
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $954K | ﹤0.01% |
53,053
+39,318
| +286% | +$707K |
|
2804
American Superconductor
AMSC
$2.26B
| $950K | ﹤0.01% |
108,469
+616
| +0.6% | +$5.4K |
|
|
IMAB
2805
I-MAB
IMAB
$376M
| $942K | ﹤0.01% |
58,000
-14,600
| -20% | -$237K |
|
2806
Teekay
TK
$734M
| $941K | ﹤0.01% |
284,345
+62,993
| +28% | +$208K |
|
|
VIEW
2807
DELISTED
View, Inc. Class A Common Stock
VIEW
| $940K | ﹤0.01% |
7,124
-149
| -2% | -$19.7K |
|
|
ENDP
2808
DELISTED
Endo International plc
ENDP
| $935K | ﹤0.01% |
399,766
| – | – |
|
2809
Citi Trends
CTRN
$314M
| $933K | ﹤0.01% |
26,056
-2,032
| -7% | -$72.8K |
|
2810
Safe Bulkers
SB
$456M
| $931K | ﹤0.01% |
204,706
-7,558
| -4% | -$34.4K |
|
2811
Bioventus
BVS
$482M
| $928K | ﹤0.01% |
67,586
+1,935
| +3% | +$26.6K |
|
2812
Ituran Location and Control
ITRN
$685M
| $928K | ﹤0.01% |
40,302
| – | – |
|
|
KNTE
2813
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $925K | ﹤0.01% |
91,945
+2,069
| +2% | +$20.8K |
|
|
CBAY
2814
DELISTED
Cymabay Therapeutics
CBAY
| $924K | ﹤0.01% |
287,914
+5,245
| +2% | +$16.8K |
|
2815
InfuSystem Holdings
INFU
$213M
| $921K | ﹤0.01% |
83,744
+879
| +1% | +$9.67K |
|
|
DADA
2816
DELISTED
Dada Nexus
DADA
| $911K | ﹤0.01% |
99,800
-17,518
| -15% | -$160K |
|
|
FRBK
2817
DELISTED
Republic First Bancorp Inc
FRBK
| $909K | ﹤0.01% |
172,748
+20,542
| +13% | +$108K |
|
2818
Aviat Networks
AVNW
$285M
| $903K | ﹤0.01% |
31,215
-541
| -2% | -$15.7K |
|
|
SFT
2819
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $902K | ﹤0.01% |
33,661
-9,541
| -22% | -$256K |
|
2820
Investors Title Co
ITIC
$471M
| $898K | ﹤0.01% |
4,405
-94
| -2% | -$19.2K |
|
|
BHR
2821
Braemar Hotels & Resorts
BHR
$203M
| $897K | ﹤0.01% |
152,746
+2,187
| +1% | +$12.8K |
|
2822
NWPX Infrastructure, Inc. Common Stock
NWPX
$503M
| $894K | ﹤0.01% |
33,947
-851
| -2% | -$22.4K |
|
2823
Cognyte Software
CGNT
$617M
| $888K | ﹤0.01% |
78,481
| – | – |
|
2824
CorMedix
CRMD
$952M
| $880K | ﹤0.01% |
177,925
+1,329
| +0.8% | +$6.57K |
|
|
ATCX
2825
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $880K | ﹤0.01% |
71,429
-71,197
| -50% | -$877K |
|